ncRNADetailInformation

Detail Information
Functional analysis

miRNA name

pre-miRNA

family

pre-miRNA Sequence

mature-miRNA

mature sequence

pre-miRNA description

miR-503

MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0022925 hsa-miR-503-3p	GGGGUAUUGUUUCCGCUGCCAGG
MI0003188	MIPF0000183	UGCCCUAGCAGCGGGAACAGUUCUGCAGUGAGCGAUCGGUGCUCUGGGGUAUUGUUUCCGCUGCCAGGGUA	MIMAT0002874 hsa-miR-503-5p	UAGCAGCGGGAACAGUUCUGCAG

link to database

TargetScanS 6.2 | MicroCosm | microRNA.org | miRNAMap 2.0

Interacted genes from RAID,miRTarBase

MRPL10,DCLRE1A,CCNE1,ERCC1,PIK3R4,CDKN1A,MT1E,MTPN,VEGFA,DLST,SPNS1,RPL23,TUT1,ATP6V1B2,MRPS23
more » MRPL10,DCLRE1A,CCNE1,ERCC1,PIK3R4,CDKN1A,MT1E,MTPN,VEGFA,DLST,SPNS1,RPL23,TUT1,ATP6V1B2,MRPS23,HNRNPK,CUZD1,CDK12,ATF6,B4GALT5,MCM7,C20orf20,CELF1,ABCB1,IVD,NUCKS1,RPL15,SIAH2,CTSA,CCNE2,UBFD1,SBF1,FGF2,WEE1,KIAA1671,CDC25A,RPS6KA3,CCND1,CCNG2,SF3B3,ANLN,CHEK1,ABCC1,CMTM4,BIRC5,HEXIM1,CCNF,WBSCR16,CTSD,AHSA1,KIAA0895L,HDGF,CLTC,BCL2,TOMM20,RPS5,FARSA,RPL18A,LIX1L,EIF2C1,DHFR,UHMK1

KEGG pathways enriched for interacted genes

pathway name

pathway description

target genes enrich in pathway

p-value

hsa04110	Cell cycle	CCND1,CCNE2,CDC14A,MCM7,CDC25A,CHEK1,WEE1,CDKN1A,CCNE1,	1.13E-6
hsa04115	p53 signaling pathway	CCND1,CCNE2,CHEK1,CDKN1A,CCNE1,CCNG2,	7.59E-5
hsa05215	Prostate cancer	CCND1,CCNE2,BCL2,CDKN1A,CCNE1,	2.72E-2
hsa05200	Pathways in cancer	CCND1,CCNE2,BCL2,VEGFA,FGF2,BIRC5,CDKN1A,CCNE1,	5.15E-2
hsa05222	Small cell lung cancer	CCND1,CCNE2,BCL2,CCNE1,	1.80E-1

Gene ontology terms enriched for interacted genes

GO terms

GO terms description

target genes enrich in GO term

p-value

GO:0007049	cell cycle	CCND1,CDC14A,BCL2,DCLRE1A,MCM7,CHEK1,BIRC5,WEE1,CDKN1A,UHMK1,ANLN,CUZD1,CCNE2,CCNF,CDC25A,SIAH2,CCNE1,CCNG2,	2.18E-9
GO:0051301	cell division	CUZD1,CCND1,CCNE2,CCNF,CDC14A,DCLRE1A,CDC25A,BIRC5,WEE1,CCNE1,ANLN,CCNG2,	1.20E-8
GO:0000278	mitotic cell cycle	CCND1,CCNF,BCL2,DCLRE1A,CDC25A,BIRC5,CHEK1,WEE1,CDKN1A,CCNE1,ANLN,CCNG2,	1.22E-7
GO:0022403	cell cycle phase	CCND1,CCNF,BCL2,DCLRE1A,CDC25A,BIRC5,CHEK1,WEE1,CDKN1A,CCNE1,ANLN,CCNG2,	3.76E-7
GO:0022402	cell cycle process	CCND1,BCL2,DCLRE1A,BIRC5,CHEK1,WEE1,CDKN1A,UHMK1,ANLN,CCNF,CDC25A,CCNE1,CCNG2,	1.11E-6

GO:0000079	regulation of cyclin-dependent protein kinase activity	CCND1,CCNE2,CDC25A,HEXIM1,CHEK1,CDKN1A,	1.89E-6
GO:0051329	interphase of mitotic cell cycle	CCND1,BCL2,CDC25A,BIRC5,CHEK1,CDKN1A,CCNE1,	2.57E-6
GO:0051325	interphase	CCND1,BCL2,CDC25A,BIRC5,CHEK1,CDKN1A,CCNE1,	3.04E-6
GO:0051726	regulation of cell cycle	CCND1,CCNE2,BCL2,CDC25A,HEXIM1,BIRC5,CHEK1,CDKN1A,ANLN,CCNG2,	4.10E-6
GO:0051412	response to corticosterone stimulus	CCND1,BCL2,CDKN1A,CCNE1,	2.89E-5
GO:0051385	response to mineralocorticoid stimulus	CCND1,BCL2,CDKN1A,CCNE1,	5.83E-5
GO:0000082	G1/S transition of mitotic cell cycle	CCND1,BCL2,CDC25A,CDKN1A,CCNE1,	6.15E-5
GO:0031099	regeneration	MTPN,CCND1,BCL2,CDKN1A,CCNE1,	1.39E-4
GO:0007067	mitosis	CCNF,DCLRE1A,CDC25A,BIRC5,WEE1,ANLN,CCNG2,	1.88E-4
GO:0000280	nuclear division	CCNF,DCLRE1A,CDC25A,BIRC5,WEE1,ANLN,CCNG2,	1.88E-4
GO:0000087	M phase of mitotic cell cycle	CCNF,DCLRE1A,CDC25A,BIRC5,WEE1,ANLN,CCNG2,	2.07E-4
GO:0048285	organelle fission	CCNF,DCLRE1A,CDC25A,BIRC5,WEE1,ANLN,CCNG2,	2.34E-4
GO:0000279	M phase	CCNF,DCLRE1A,CDC25A,BIRC5,CHEK1,WEE1,ANLN,CCNG2,	2.46E-4
GO:0006793	phosphorus metabolic process	CCND1,BCL2,CDC14A,PIK3R4,CDK12,CHEK1,WEE1,UHMK1,RPS6KA3,CDC25A,FGF2,SBF1,ATP6V1B2,	2.51E-4
GO:0006796	phosphate metabolic process	CCND1,BCL2,CDC14A,PIK3R4,CDK12,CHEK1,WEE1,UHMK1,RPS6KA3,CDC25A,FGF2,SBF1,ATP6V1B2,	2.51E-4
GO:0042325	regulation of phosphorylation	CCND1,CCNE2,BCL2,MCM7,FGF2,CDC25A,HEXIM1,CHEK1,CDKN1A,	3.70E-4
GO:0000075	cell cycle checkpoint	CCND1,CCNE2,BIRC5,CHEK1,CCNG2,	4.05E-4
GO:0051174	regulation of phosphorus metabolic process	CCND1,CCNE2,BCL2,MCM7,FGF2,CDC25A,HEXIM1,CHEK1,CDKN1A,	4.83E-4
GO:0019220	regulation of phosphate metabolic process	CCND1,CCNE2,BCL2,MCM7,FGF2,CDC25A,HEXIM1,CHEK1,CDKN1A,	4.83E-4
GO:0008406	gonad development	CCND1,ERCC1,BCL2,VEGFA,CCNE1,	8.87E-4
GO:0010608	posttranscriptional regulation of gene expression	MTPN,BCL2,VEGFA,EIF2C1,RPS5,CELF1,	1.26E-2
GO:0008283	cell proliferation	CUZD1,ERCC1,BCL2,CDC14A,VEGFA,MCM7,CDC25A,HDGF,	1.31E-2
GO:0033554	cellular response to stress	CCND1,ERCC1,BCL2,DCLRE1A,MCM7,ATF6,CHEK1,CDKN1A,CTSD,	1.32E-2
GO:0048608	reproductive structure development	CCND1,ERCC1,BCL2,VEGFA,CCNE1,	1.37E-2
GO:0042493	response to drug	CCND1,BCL2,ABCB1,ABCC1,CDKN1A,CCNE1,	1.39E-2
GO:0045137	development of primary sexual characteristics	CCND1,ERCC1,BCL2,VEGFA,CCNE1,	1.41E-2
GO:0009411	response to UV	CCND1,ERCC1,BCL2,CDKN1A,	1.49E-2
GO:0045859	regulation of protein kinase activity	CCND1,CCNE2,FGF2,CDC25A,HEXIM1,CHEK1,CDKN1A,	1.99E-2
GO:0043549	regulation of kinase activity	CCND1,CCNE2,FGF2,CDC25A,HEXIM1,CHEK1,CDKN1A,	2.36E-2
GO:0007548	sex differentiation	CCND1,ERCC1,BCL2,VEGFA,CCNE1,	2.66E-2
GO:0032845	negative regulation of homeostatic process	ERCC1,BCL2,VEGFA,	2.90E-2
GO:0000086	G2/M transition of mitotic cell cycle	BIRC5,CHEK1,CDKN1A,	2.90E-2
GO:0051338	regulation of transferase activity	CCND1,CCNE2,FGF2,CDC25A,HEXIM1,CHEK1,CDKN1A,	2.90E-2
GO:0016310	phosphorylation	CCND1,RPS6KA3,BCL2,FGF2,PIK3R4,CHEK1,CDK12,WEE1,ATP6V1B2,UHMK1,	3.13E-2
GO:0003006	reproductive developmental process	CCND1,ERCC1,BCL2,VEGFA,CCNE1,CELF1,	3.24E-2
GO:0051384	response to glucocorticoid stimulus	CCND1,BCL2,CDKN1A,CCNE1,	3.32E-2
GO:0006468	protein amino acid phosphorylation	CCND1,RPS6KA3,BCL2,FGF2,PIK3R4,CHEK1,CDK12,WEE1,UHMK1,	3.68E-2
GO:0031960	response to corticosteroid stimulus	CCND1,BCL2,CDKN1A,CCNE1,	4.23E-2
GO:0031100	organ regeneration	CCND1,CDKN1A,CCNE1,	4.43E-2
GO:0006414	translational elongation	RPL23,RPL18A,RPS5,RPL15,	6.84E-2
GO:0033197	response to vitamin E	CCND1,CCNE1,	7.67E-2
GO:0006412	translation	FARSA,RPL23,RPL18A,MRPL10,RPS5,RPL15,	8.63E-2
GO:0009991	response to extracellular stimulus	CCND1,BCL2,CDKN1A,CTSD,CCNE1,	1.00E-1

KEGG pathways and Gene Ontology terms enriched for the interacted genes of ncRNA from RAID and miRTarBase.

disease name	related genes	p-value